Screener
Bruker BRKR Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Bruker’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335226
FAQ
- What is Bruker's cash & equivalents?
- Bruker (BRKR) reported cash & equivalents of $189.1M in Q2 2026.
- How has Bruker's cash & equivalents changed year-over-year?
- Bruker's cash & equivalents increased by 96.6% year-over-year, from $96.2M to $189.1M.
- What is the long-term trend for Bruker's cash & equivalents?
- Over 5 years (2020 to 2025), Bruker's cash & equivalents has grown at a -15.1% compound annual growth rate (CAGR), from $685.5M to $303.1M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Bruker's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude